The End of the Beginning of the Alzheimer’s Disease Nightmare: A Devil’s Advocate’s View
Author:
Affiliation:
1. Department of Neurobiology, Division of Neurogeriatrics, Care Sciences and Society, Karolinska Institute, Huddinge, Sweden
Publisher
IOS Press
Subject
Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience
Reference24 articles.
1. Defeating Alzheimer’s disease and other dementias: A priority for European science and society;Winblad;Lancet Neurol,2016
2. The worldwide costs of dementia 2015 and comparisons with 2010;Wimo;Alzheimers Dement,2016
3. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial;Ngandu;Lancet,2015
4. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Sperling;Alzheimers Dement,2011
5. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Albert;Alzheimers Dement,2011
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Microglial ApoD‐induced NLRC4 inflammasome activation promotes Alzheimer's disease progression;Animal Models and Experimental Medicine;2024-03-23
2. Optimising Alzheimer’s Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment;The Journal of Prevention of Alzheimer's Disease;2024
3. Using dynamic microsimulation to project cognitive function in the elderly population;PLOS ONE;2022-09-15
4. Should Doctors Offer Biomarker Testing to Those Afraid to Develop Alzheimer’s Dementia?;Journal of Bioethical Inquiry;2022-03-19
5. A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer’s Disease: Results from the MOPEAD Project;Journal of Alzheimer's Disease;2021-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3